EGFR and triple-negative breast carcinoma: Consequently, treatment with sequential injections of Doxy@CaCO3-PEG and Tet-HER1-CAR-T cells synergistically inhibited the growth of HER1-overexpressing subcutaneous triple-negative breast cancer (TNBC), lung cancer, erlotinib-resistant TNBC and orthotopic lung cancer.